Roger G. Stoll Ph.D., Director at Chelsea Therapeutics International, Ltd. (CHTP), bought 5,000 shares at $5.37 ($27K) on 2008-06-02, disclosed to the SEC on 2008-06-04.
Open-market purchase of $27k CHTP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.37 | 200 | $1K | 3.9% |
| 2 | $5.43 | 300 | $2K | 6.0% |
| 3 | $5.44 | 1,300 | $7K | 25.9% |
| 4 | $5.45 | 200 | $1K | 4.0% |
| 5 | $5.47 | 400 | $2K | 8.0% |
| 6 | $5.48 | 100 |
| $548 |
| 2.0% |
| 7 | $5.49 | 100 | $549 | 2.0% |
| 8 | $5.50 | 2,400 | $13K | 48.3% |
| Total | $5.47 avg | 5,000 | $27K | 100% |
| Filing → |
| DCTH | BUY | 2015-07-28 | $11K | — | Filing → |
| DCTH | BUY | 2009-11-20 | $90K | — | Filing → |
| DCTH | BUY | 2009-08-26 | $31K | — | Filing → |